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successfully implanted with a Lotus Valve with no procedural mor-
tality. All patients remained alive at 2 years, and the 2-year clinical
follow-up and TTE assessment rates were 100% (11/11). Major stroke
occurred in 1 patient on day 3, for a 2-yearmajor stroke rate of 9.1%, and
life-threatening/disabling bleeding occurred in 2 patients for a 2-year
rate of 18.2%. Conduction disturbance requiring new permanent
pacemaker implantation remained at 4 patients. There were no repeat
hospitalizations for valve-related symptoms or cardiac decompensa-
tion. Mean aortic gradient was 15.54.4mmHg and mean effective
oriﬁce area was 1.510.19cm2 at 2 years. All (100%) patients remained
in New York Heart Association Class I or II. Core laboratory adjudicated
paravalvular aortic regurgitation was not evaluable in 1 patient, trace/
trivial in 1 patient, mild in 1 patient, and absent in 8 patients at 2 years.
CONCLUSIONS Two-year feasibility results suggest that the Lotus
Valve has minimal aortic regurgitation and low clinical event rates
sustained through 2 years. Three-year outcomes from REPRISE I will
be available for presentation for the ﬁrst time at TCT 2015.
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BACKGROUND With the beginning of transcatheter aortic valve im-
plantation (TAVI), the use of active-ﬁxation leads combined with
externalized re-usable permanent pacemakers was initiated to
improve lead stability, increase patient mobility and facilitate
handling for nursing staff. Experience and beneﬁts of temporary
permanent pacemaker (TPPM) systems have thus far mainly been
reported in patients suffering from cardiovascular implantable elec-
tronic device (CIED) infection. The aim was to investigate the safety
and efﬁcacy of TPPMs for periprocedural rapid ventricular pacing and
postprocedural back-up pacing in patients undergoing transcatheter
aortic valve implantation (TAVI).
METHODS Between November 2008 and April 2015, a temporary
permanent pacemaker system was implanted in 108 consecutive TAVI
patients. An active-ﬁxation right-ventricular lead was implanted in
either an apical or septal position via the right internal jugular vein
using a 7 French peel-away introducer sheet. Pacing treshold was
considered acceptable if <1.0 V at a pulse width of 0.5 ms, as were R-
wave sensing amplitudes > 10 mV. The lead was then sutured to the
patient’s neck and connected to a re-usable permanent pacemaker
programmed in VVI mode. Finally, the pacemaker and lead were
taped to the patient’s skin in typical infraclavicular position.RESULTS Mean patients’ age was 81.1  4.9 years and mean dura-
tion of TPPM was 5.6  2.1 (range 2-14) days. After successful pri-
mary implantation in all patients without any procedure-related
complications deﬁned as pneumothorax, pericardial effusion with
hemodynamic relevance and local infection or hematoma, lead
dislocation and necessity of lead repositioning occurred in one
patient (0.92%).Patients 108Male (female) 44 (64)Age (years) 81.1  4.9
Success of temporary lead implantation, n (%) 108 (100)Apical positioning, n (%) 68 (63)Septal positioning, n (%) 40 (37)No. of days TPPM (range) 5.6  2.1 (2-14)
Procedure-related complications 0Lead dislocation, n (%) 1 (0.92)CONCLUSIONS Temporary permanent pacemakers using active-ﬁxa-
tion leads are safe and effective in TAVI procedure, providing a stable
pacing mechanism with a low rate of lead dislocation.
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BACKGROUND Different studies have compared the rate of more-
than-mild aortic regurgitation (AR) between Corevalve (MCS) and
Edwards-SAPIEN valve (ESV) with different results. Aortic root calci-
ﬁcation has been also related with AR. For the time being, no study
reported the rate of signiﬁcant AR between these 2 devices in relation
with the aortic root anatomy.
METHODS All consecutive patients (p) who underwent transcatheter
aortic valve replacement (TAVR) with a MCS or ESV (ESV-XT or ESV-
Sapien 3) and a good image quality CT-scan were included. Aortic root
calcium was assessed by using the modiﬁed Agatston score, from left
main to the nadir of the aortic annulus leaﬂets. Paravalvular AR was
assessed by aortography at least 10 minutes post TAVR. Based on
annulus eccentricity and Agatston score 4 phenotypes (Ph) were
identiﬁed: - Ph 1: Mildly calciﬁed aortic root and circular annulus. - Ph
2: Mildly calciﬁed aortic root and elliptical annulus. - Ph 3: Severely
calciﬁed aortic root and circular annulus. - Ph 4: Severely calciﬁed
aortic root and elliptical annulus.
RESULTS A total of 248 p were included in the analysis (MCS¼196;
ESV 52). The distribution of phenotypes was as follows: for ES, ph 1
was present in 13 p (25.0 %), ph 2 in 13 p (25.0%), ph 3 in 14 p (26.9 %)
and ph 4 in 12 p (23.1%). For MCS ph 1 was present in 59 p (30.1 %), ph 2
in 46 (23.5 %), ph 3 in 49 p (25.0%) and ph 4 in 42 p (21.4 %). Seventy-
one p (28.6 %) patients had more than mild paravalvular AR, 7.7 % of
patients with ES (4 p.) and 28.6 % (67 p) with MCS. Overall, Agatston
score (4204  1990 vs. 3433  3269, p¼0.065) and eccentricity of the
annulus (18.9  8.2 vs. 15.9  8.5, p¼0.092) were higher in patients
with more-than-mild AR. In mildly calciﬁed aortic roots, there were
not differences between both devices in the rate of signiﬁcant AR
(MCS 16.2 % vs. ESV 11.5%, p¼0.56). In severely calciﬁed aortic roots,
more than mild AR was more frequent after TAVR with MCS (MCS
54.9% vs. ESV 4.0 %, p¼< 0.0001). In the analysis per ph, there were
not signiﬁcant differences in the rate of AR per device for phenotype 1
and 2. In ph 3 and 4 more than mild paravalvular AR was more
frequent with MCS (Figure).
CONCLUSIONS In heavily calciﬁed roots, TAVR with ESV seems to be
associated with less paravalvular AR in comparison with MCS. In
mildly calciﬁed aortic roots the rate of signiﬁcant AR is similar be-
tween both devices.
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BACKGROUND Despite clinical trial evidence supporting the efﬁcacy
of transcatheter aortic valve replacement (TAVR), questions remain
regarding outcomes of TAVR among very elderly patients, who are
often considered high risk simply due to age. Little is known about the
outcomes of nonagenarians undergoing TAVR in current clinical
practice.
METHODS National U.S. data from the Society of Thoracic Surgeons/
American College of Cardiology Transcatheter Valve Therapy (STS/
ACC TVT) Registry was evaluated. Outcomes at 30-days and 1-year
were compared between patients 90 vs <90 years of age using cu-
mulative incidence curves. For non-fatal outcomes, including stroke,
heart failure readmission, aortic valve reintervention and post-
procedural myocardial infarction, death was considered a competing
risk.
RESULTS Between November 2011 - September 2014, 24,025 patients
underwent TAVR in 329 participating hospitals, of which 3773 (15.7%)
were age 90. Nonagenarians (vs <90) had slower ﬁve meter walk
tests (8.7 sec vs 8.0 sec), higher STS Predicted Risk of Mortality Score
(9.2% vs 6.3%) and yet reported better health status prior to TAVR
(KCCQ-OS scores: 41.7 vs 37.5). The 30-day (8.8% vs 5.9%) and 1-year
(24.8% vs 22.0%) mortality was signiﬁcantly higher among
patients 90 years old (see Figure 1; absolute risk 2.8%, relative risk
12.7%). There was also a higher rate of heart failure readmission after
30 days (5.3% vs 4.3%) but not after 1 year (14.9% vs 14.5%). No dif-
ferences in stroke rate, aortic valve reintervention or myocardial
infarction were seen after 30 days or 1 year.CONCLUSIONS In current U.S. clinical practice, approximately 16% of
TAVR patients are 90 years of age. Although 30-day and 1-year
mortality was statistically higher compared with younger TAVR pa-
tients, the absolute and relative differences were clinically modest.
These data support safety and efﬁcacy of TAVR in selected older
patients.
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BACKGROUND Accurate assessment of cardiac output (CO) is essen-
tial for the hemodynamic assessment of cardiac patients and espe-
cially in the setting of valve disease. Estimation of oxygen
consumption (VO2) is employed in many cardiac catheterization lab-
oratories given the historically cumbersome nature of direct VO2
measurement, the “gold standard” for this technique. Thermodilution
(TD) is used instead of assumed VO2 in many labs as well. We
compared direct VO2 CO and aortic valve area (AVA) to those based on
assumed VO2 and TD in patients with suspected aortic stenosis.
METHODS Thirty consecutive patients undergoing right heart cathe-
terization had simultaneous determination of CO by both direct and
assumed VO2 and TD. A portable facemask device allowed the direct
measurement of VO2. All measurements of direct and assumed VO2,
as well as, TD CO were obtained in triplicate.
RESULTS Directly measured VO2 CO and estimated VO2 CO calcu-
lations correlated poorly (R¼ 0.57; ICC ¼0.59). Directly measured
VO2 CO and thermodilution CO calculations correlated poorly, as
well (R¼ 0.51; ICC ¼0.60). Furthermore, when the CO from these
different methods of VO2 measurement was utilized to calculate
aortic valve areas, those areas derived from directly measured and
estimated VO2 values correlated poorly as well (R¼ 0.68; ICC ¼0.55).
Similarly, the correlation between AVA, in those patients in whom it
was the focus of the catheterization, based on direct VO2 and TD was
poor (R¼ 0.66; ICC ¼0.60). Using a constant assumed VO2 value led
to a large discrepancy in repeated CO measurement during the case
(R¼ 0.62; ICC ¼0.57). Repeated TD CO was associated with less
discrepancy (R¼ 0.78; ICC ¼0.84). Although directly measured VO2
